ArticleCureus2025
A Rare Presentation of a Fibrous Breast Hamartoma Requiring Careful Imaging Assessment.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast hamartomas are benign disorders and are generally composed of breast-constituting pathological components, mainly fat components. A 68-year-old woman was found to have a left breast mass on computed tomography (CT) for coronary artery evaluation due to suspected angina pectoris. Mammography showed a well-defined oval mass, 2.7 cm in size, without obvious fat findings in the upper and outer quadrant of her left breast. Ultrasound showed a well-circumscribed mass with predominant low internal echoes, high internal echoes in very small areas, weakly enhanced posterior echoes, and no blood flow into and around the mass. Magnetic resonance imaging (MRI) of the breast mass showed low signals on T1-weighted images, predominant low signals on fat-suppressed T2-weighted images, and no enhancement through early-to-late-phase images on dynamic studies. The patient, therefore, underwent a core needle biopsy, which unfortunately only showed abundant fibrous components and no malignant cells, leading to no definitive pathological diagnosis. We, therefore, treated the breast mass with a lumpectomy to get both a pathological diagnosis and a cure of the presumed benign breast mass. The bisected mass had whitish cut surfaces except for the core needle biopsy-induced hemorrhage areas. Postoperative pathological study showed predominant fibrous components, a small amount of adipocytes, and sparse mammary duct-lobular structures in the fibrous components, leading to the diagnosis of fibrous breast hamartoma. The patient recovered uneventfully and is scheduled to receive annual mammography follow-ups. Diagnostic physicians should note that breast hamartomas can have predominant fibrous components.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.